Nanotechnology Now - Press Release: "Starpharma Holdings Ltd (ASX:SPL) Quarterly Activities Report to Dec 31, 2008"

Home > Press > Starpharma Holdings Ltd (ASX:SPL) Quarterly Activities Report to Dec 31, 2008

Abstract:
Starpharma Holdings Ltd (ASX:SPL)(PINK:SPHRY) Quarterly Activities Report to Dec 31, 2008

Starpharma Holdings Ltd (ASX:SPL) Quarterly Activities Report to Dec 31, 2008

Melbourne, Australia | Posted on February 2nd, 2009

www.abnnewswire.net/media/en/docs/60034-ASX-SPL-313003.pdf

####

About Starpharma Holdings Ltd
Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) is a world leader in the development of dendrimer nanotechnology for pharmaceutical, life-science and other applications. SPL is principally composed of two operating companies, Starpharma Pty Ltd in Melbourne, Australia and Dendritic Nanotechnologies, Inc in Michigan, USA. Products based on SPL's dendrimer technology are already on the market in the form of diagnostic elements and laboratory reagents.

The Company's lead pharmaceutical development product is VivaGel(R) (SPL7013 Gel), a vaginal microbicide designed to prevent the transmission of STIs, including HIV and genital herpes.

For more information, please click here

Contacts:
Dr Jackie Fairley
Chief Executive Officer
TEL: +61-3-8532-2704

Ben Rogers
Company Secretary
TEL: +61-3-8532-2702

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:

Related News Press